The purpose of this study is to investigate the morphometric changes of the subchondral bone during the development of osteoarthritis (OA) in transgenic mice with achondroplasia (Fgfr3 ach ) carrying a heterozygous gain-of-function mutation in Fgfr3. Two OA models (spontaneously developed with age: The aging model, and surgically induced by destabilization of the medial meniscus: The DMM model) were established. Articular cartilage, epiphysis, and metaphysis of the knee joint were histologically and morphometrically compared between wild-type mice, and Fgfr3 ach mice in both OA models. Articular cartilage degeneration was scored according to the Osteoarthritis Research Society International (OARSI) scoring system. Several morphometric parameters including bone mineral density (BMD), bone volume/tissue volume (BV/TV), trabecular bone thickness (Tb.Th), and subchondral bone thickness in the medial tibial plateau (MTP) (Sb.Th med) were quantified by micro-computed tomography (CT). In the aging model, although there were no significant differences in the OARSI score between wild-type mice and Keywords: fibroblast growth factor receptor 3 (FGFR3); achondroplasia; osteoarthritis; subchondral bone sclerosis; mouse model Osteoarthritis (OA) is a representative degenerative joint disease, which affects not only articular cartilage but also subchondral bone.
Osteoarthritis (OA) is a representative degenerative joint disease, which affects not only articular cartilage but also subchondral bone. 1 Subchondral sclerotic bone change is considered as a hallmark and indisputable sign of progression of OA. [2] [3] [4] Using experimental OA models, several studies have shown the evidence that increase in thickness of subchondral bone plate became apparent prior to degradation of articular cartilage, and cartilage degeneration particularly progressed in the regions of subchondral sclerosis. [5] [6] [7] [8] [9] Subchondral sclerosis, thus, seems to be closely related to the initiation and progression of the disease. 10, 11 Achondroplasia (ACH), which is the most common short-limbed skeletal dysplasia, is caused by gainof-function mutations in the fibroblast growth factor receptor 3 (FGFR3) gene. FGFR3 is a negative regulator of endochondral bone growth. 12, 13 FGFR3 is highly expressed in the proliferative and prehypertrophic chondrocytes of the growth plate 14 and overexpression of FGFR3 signaling in the growth plate impairs longitudinal bone growth by inhibiting proliferation and terminal differentiation of chondrocytes. [15] [16] [17] FGFR3 is also expressed in articular chondrocytes [18] [19] [20] [21] and contributes articular cartilage homeostasis 22 in mouse and human. Valverde-Franco et al. 23 showed that the absence of FGFR3 signaling in the joints of Fgfr3 À/À mice led to premature cartilage degeneration and early arthritis. Recently, Tang et al. 24 indicated that adult mice carrying conditional Fgfr3 deletion in chondrocytes caused aggravated cartilage degeneration after OA-induced surgery. Conversely, chondrocyte-specific Fgfr3 activation ameliorated cartilage degeneration via downregulation of Indian hedgehog signaling in articular chondrocytes. 24 Using spontaneous age-related and surgically induced OA models in wild-type mice and transgenic mice with ACH, we performed histological and morphometric analyses of articular cartilage during the development of OA specifically focused on morphology of the subchondral bone.
MATERIALS AND METHODS

Mice
Fgfr3
ach mice (FVB background), employed as a model mimicking of human ACH, were provided by Dr. David M. Ornitz at Washington University. 25 Briefly, Fgfr3 ach mice express an activated FGFR3, containing the G380R mutation responsible for ACH in the growth plate using the Col2a1 promoter and enhancer sequences. In all experiments, we used male transgenic mice carrying the heterozygous Fgfr3 ach transgene. The mice were housed under a 12-h light-dark cycle and were provided with water, and standard commercial diet ad libitum. All animal experiments were approved by the Animal Care and Use Committee of our institution.
Aging OA Model
For spontaneous age-related OA models, knee joints were harvested from untreated Fgfr3 ach mice and wild-type mice at two different age groups (18 weeks of age and 12 months of age). We analyzed the cartilage degeneration at 12 months of age as the aging OA model according to the recommendations of the Osteoarthritis Research Society International (OARSI). 26 Samples were used either histological analysis or bone morphometric measurements. Four wild-type mice and four Fgfr3 ach mice were included for analyzing the aging OA model.
DMM OA Model
Surgically induced OA model was created in the right knee joint by destabilization of the medial meniscus (DMM) surgery as described by Glasson et al. 27 In short, the knee joint was exposed with a medial capsular incision followed by gentle lateral displacement of the extensor mechanism under aseptic condition. Then, the medial meniscotibial ligament was sectioned to destabilize the medial meniscus. After reducing the extensor mechanism, the joint capsule and skin were closed. The surgery was performed using a microscope under general anesthesia. Sham operation was performed in the contralateral left knee with incision of the skin and joint capsule. We analyzed a total of nine kinships. Eleven Fgfr3 ach mice and 14 wild-type mice finally underwent DMM surgery at the age of 10 weeks. Similar to the progression of human OA, the DMM model provided mild-to-moderate OA and moderate-to-severe OA at postoperative 4 and 8 weeks, respectively. 27 We thus sacrificed the mice at the age of 14 or 18 weeks. We finally evaluated four Fgfr3 ach mice and six wild-type mice at 4 weeks after surgery, and seven Fgfr3 ach mice and eight wild-type mice at 8 weeks after surgery, respectively.
Histologic Analysis
Mice were transcardially perfused with 4% paraformaldehyde (PFA, Sigma-Aldrich Japan, Tokyo, Japan) under general anesthesia, and the knee joint was postfixed in 4% PFA at room temperature for 24 h. After washing with phosphate buffered saline (PBS, Sigma-Aldrich Co., St. Louis, MO), the samples were decalcified in 10% EDTA solution (Sigma-Aldrich Japan, Tokyo, Japan) at 4˚C for 3 weeks and then embedded in paraffin. Coronal thin sections (5 mm) were cut and stained with Safranin O/Fast green (SO/FG), and used for OA evaluation. We obtained 10 serial coronal sections per each knee joint. Severity of OA was scored according to the OARSI scoring system. 28 In the maximally affected coronal section, the MTP, medial femoral condyle (MFC), lateral tibial plateau (LTP), and lateral femoral condyle (LFC) were scored on a scale of 0-6 according to the OARSI score. 28 We also evaluated the summed OARSI scores of 10 serial coronal sections per each knee joint.
Radiographic Analysis Using Micro-Computed Tomography
For radiographic analysis of the knee joints, the mice were subjected to micro-CT scan (Skyscan 1176, Bruker, Kontich, Belgium). For the image acquisition, the following parameters were used; X-ray voltage 50 kV, X-ray current 500 mA, 0.5 mm Al filter, rotation step 0.5 degree, pixel size 9 mm, no frame averaging. After reconstruction by using the Skyscan NRecon software, the images were analyzed by using threedimensional (3D) algorithms in Skyscan CTAn software according to the manufacturer's instructions. The trabecular bone in the metaphysis and proximal medial epiphysis of the tibia was selected as region of interest (ROI) (Supplementary Fig. S1 ). To quantify the characteristics of the subchondral bone, the epiphysis was further separated into a cortical part (subchondral bone plate) and underlying a trabecular part (Supplementary Fig. S1A and B). 29 A subset (500 mm mediolateral width, 1,000 mm ventrodorsal length) of the weight-bearing region at the medial side of the tibial plateau was taken as the epiphyseal ROI according to the method of Botter et al. 29 The 1,200 mm section starting from 300 mm below the growth plate was selected as metaphyseal trabecular ROI ( Supplementary Fig. S1C ). Bone volume/ total volume (BV/TV, in %) and trabecular thickness (Tb.Th, in micrometer) were calculated to describe epiphyseal and metaphyseal trabecular compartments. To describe the subchondral bone plate in the MTP, we measured the average thickness (Sb.Th med, in micrometer) using the same algorithm as used for determining Tb.Th. The DSb.Th med was calculated as an increased Sb.Th med in the DMM side compared with that in the sham side of same individual. For calculation of the bone mineral density (BMD) at the same sites of BV/TV measurements, calibration of the Skycan CT system was performed against a 0.25 and a 0.75 g/cm 3 hydroxyapatite phantom.
Statistical Analysis
All data are expressed as the mean AE SD. Group means were compared using Student's t-test. The P values less than 0.05 were considered significant. All analyses were performed using SPSS software for Windows, version 23.0.
We calculated that an expected effect size, Cohen's d, 30 was 2.31 in the aging OA model and 1.97 in the DMM OA model, respectively, based on the previous report that addressed the data of Sb.Th med in both models. 31 Power analysis was performed using G Ã Power 3.1.9.2 32 utilizing an a value of 0.05 and a power (1-b) value of 0.80 for the t-test. The priori minimum sample size was calculated as n ¼ 4 in the aging model and n ¼ 5 in the DMM model per group, respectively.
RESULTS
Subchondral Bone Thickness Was Increased Prior to Cartilage Degeneration in Wild-Type Mice Aged 12 Months
We first analyzed the natural course of OA development using wild-type mice at the age of 18 weeks and 12 months. There were no significant differences in both maximal and summed OARSI scores between mice aged 18 weeks and 12 months (Figs. 1A and B, and S2). The reconstructed images of the micro-CT scan demonstrated that the Sb.Th med was significantly increased in mice at the age of 12 months than in mice at the age of 18 weeks (Fig. 1C and D) . These results indicated that subchondral bone sclerosis occurred prior to cartilage degradation. Fig. 1E and F) . The OARSI scores in Fgfr3 ach mice also showed no differences between both age groups ( Supplementary  Fig. S3 ). Fig. 2A) . The Tb.Th value significantly increased with age in wild-type mice while unchanged in the mutant mice. In the metaphyseal trabecular bone, the BMD and BV/TV decreased from 18 weeks to 12 months of age in both mice, while the Tb.Th increased with age. These parameters, which were significantly lower in the mutant mice at the age of 18 weeks, converged in both groups at the age of 12 months (Fig. 2B) .
Activated Fgfr3 Prevented Subchondral Bone Sclerosis in
Activated Fgfr3 Suppressed Cartilage Degeneration in DMM Model
We next compared cartilage degeneration at the MTP in DMM model between wild-type mice and Fgfr3 ach mice. At 4 weeks after surgery, the articular cartilage became thinner in wild-type mice than in Fgfr3 ach mice (Fig. 3A) . The maximal and summed OARSI scores of MTP and MTP þ MFC were significantly decreased in Fgfr3 ach mice than in wild-type mice (Figs. 3B and S4) . At 8 weeks after surgery, we observed loss of articular cartilage associated with vertical cleft and erosion to the deep calcified cartilage in wild-type mice, while minimally cartilaginous defects of the superficial layer in Fgfr3 ach mice (Fig. 3A) . The OARSI scores of the medial compartment (MTP, MFC, MTP þ MFC) were significantly 
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decreased in Fgfr3
ach mice than in wild-type mice (Figs. 3B and S4 ). There were no significant differences in the OARSI scores in LTP, LFC, and LTP þ LFC between wild-type mice and Fgfr3 ach mice.
Activated Fgfr3 Ameliorated Sclerosis of Subchondral Bone in DMM Model
We next compared the bone morphometric parameters of the knee joints between wild-type mice and Fgfr3 ach mice using the reconstructed images of the micro-CT scan. The 2D coronal slices showed sclerosis in the medial epiphysis of the proximal tibia in wild-type mice at 4 weeks after surgery, which became more remarkable at 8 weeks after surgery (Fig 4A) . Bone morphometric analysis demonstrated that the Sb.Th med was increased in both wild-type mice and Fgfr3 ach mice treated with DMM surgery with age ( Fig. 4B and C) . The DSb.Th med, however, was significantly smaller in Fgfr3 ach mice than that in wild-type mice at both time points after the surgery (Fig. 4C) . Additionally, DMM surgery increased the BMD, BV/TV, and Tb.Th in the epiphyseal trabecular bone of the MTP in wild-type mice while there were no statistical differences in the BMD and BV/TV at 4 weeks after surgery. These parameters, on the other hand, unchanged in Fgfr3 ach mice after surgery (Figs. 4D and S5A ). In the metaphyseal trabecular bone, osteoporotic changes were evident in Fgfr3 ach mice, but DMM surgery did not affect any bone morphometric parameters in both groups (Figs. 4E and S5B).
DISCUSSION
Using two different experimental OA models, we histologically and morphometrically demonstrated that activated FGFR3 signaling prevented subchondral bone sclerosis and subsequent cartilage degradation.
Subchondral bone sclerosis preceded cartilage degradation during the progression of OA in aging OA model of wild-type mice. Carlson et al. 5 indicated that the subchondral plate thickening was ach mice than those in wild-type mice during the study periods. The Tb.Th is significantly increased with age in wild-type mice. (B) Representative 3D-CT images of the trabecular bone architecture in the proximal tibial metaphysis at the age of 18 weeks and 12 months in wild-type mice, and Fgfr3 ach mice. The BMD and BV/TV decreased with age in both groups at the age of 12 months. The Tb.Th increased with age in both groups, and differences in this parameter, which are prominent at 18 weeks of age, decreased at 12 months of age. Mean and SD are indicated in the graphs. The statistical differences shown on each graph are analyzed by Student's t-test. 4 first demonstrated that the progression of cartilage degradation required stiffened subchondral bone. They proposed that sclerotic subchondral bone creates internal stress concentrations in cartilage that lead to deterioration of cartilage. 4 These reports indicated that subchondral bone sclerosis closely related to pathogenesis of OA.
FGFR3 PREVENTS SCLEROSIS IN OA
In The relationship between the development of OA and osteoporosis is controversial. 33 Numerous crosssectional studies have indicated that OA was associated with increased BMD. [34] [35] [36] Conversely, Bellido et al. 37 proposed that an increased subchondral bone resorption may account for the aggravation of cartilage damage. Additionally, Halloran et al. 38 demonstrated that the BV/TV decreased, but the Tb.Th increased with age in the metaphysis of the proximal tibia in age-related OA mouse model, suggesting that trabecular bone loss in aging mice was not caused by trabecular thinning. Our results supported their findings. Su et al. 39 showed that Fgfr3 G369C/þ mice had decreased bone mass in metaphyseal trabecular bone of distal femur and proximal tibia at the age of 2 and 4 months. Similarly, we indicated osteoporotic features of the 18-week-old Fgfr3 ach mice in the metaphysis. The age-related bone loss in the metaphysis was remarkable in wild-type mice but not in Fgfr3 ach mice in the present study. Additionally, DMM surgery did not change any bone morphometric parameters in the metaphysis. Metaphyseal osteoporotic changes, therefore, appeared to be unrelated to the development of OA.
Subchondral bone sclerosis could be related to bone metabolism in the epiphysis. Kumarasinghe et al. 40 suggested that an imbalance between reduced bone resorption and unchanged bone formation may lead to subchondral sclerosis. Burr and Gallant reported that the bone remodeling rate was decreased with the progression of OA. 3 Su et al. 39 demonstrated that activated FGFR3 promoted not only osteogenic differentiation but also osteoclast formation, indicating an increased bone turnover in ACH mice. Higher turnover of bone remodeling, therefore, may protect subchondral bone sclerosis in mouse model of ACH.
In regard to OA progression, there is a well-known re-establishment of the process of endochondral ossification at the tidemark. 41, 42 The calcified cartilage at the tidemark can contribute to sclerosis through endochondral ossification process, which is often seen in advanced OA. 3 The transgenic mice carrying overactivation of the Indian hedgehog (IHH) signaling showed premature cartilage degeneration associated with increased hypertrophic chondrocytes, 43 indicating that IHH signaling may upregulate the terminal differentiation of chondrocytes in articular cartilage. Activated FGFR3, on the other hand, downregulated IHH signaling in adult articular cartilage. 24 Overactivation of FGFR3 signaling could suppress endochondral ossification process by inhibiting IHH signaling at the tidemark during OA progression.
Activated FGFR3 signaling showed the protective effect on cartilage degradation during the progression of OA, which has the highest morbidity of all diseases in elderly population. Medical care for symptomatic OA patients in the United States costs $185.5 billion a year. 44 Development of revolutionary medical treatments for OA has been expected to reduce medical costs as well as to improve patients' activity of daily living. Stimulation of FGFR3 signaling in the articular cartilage could be a potential therapeutic target for OA.
There are several limitations in our study. First, subchondral bone changes during the OA progression differ between the strains of mice. Botter et al. 45 demonstrated that the subchondral bone plate thickness of the MTP was significantly different between two mouse strains; C57BL/6 and C3H/HeJ mice. The Sb. Th med of FVB wild-type mice without specific procedures in the current study seemed to be lower than that of C57BL/6 mice in previous reports. 31, 45 Second, we employed Fgfr3 ach mice among several mouse models of ACH, which may have different cartilage metabolism and chondrogenic potential. Finally, histologic and morphometric analyses of the current study could not determine the molecular mechanisms of inhibiting sclerotic changes in subchondral bone in Fgfr3 ach mice. In conclusion, using transgenic mice with ACH, we demonstrated that overexpression of FGFR3 signaling contributed to articular cartilage maintenance during the development of OA. Activated FGFR3 inhibited subchondral sclerosis, which seemed to be associated with persistent high turnover in bone remodeling and down-regulated endochondral ossification at the tidemark.
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